Leigh MacMillan Archive

August 30, 2012

Targeting new pathways to ease pain

The spinal cord’s neuropeptide Y signaling pathway may be a good target for new pain therapeutics.

August 28, 2012

Clues to retinal cell degeneration

A reversible chemical modification of rhodopsin, a receptor for light, plays a role in the degeneration of retinal cells.

August 23, 2012

VU, Lipscomb partner on dual degree program

A new cooperative program between Vanderbilt University and Lipscomb University’s College of Pharmacy is focusing on the next generation of pharmaceutical researchers. By offering a pathway for students to earn both Pharm.D. and Ph.D. degrees, the program aims to boost the number of pharmacy-trained research scientists.

August 14, 2012

Flu Tool guides patient decision-making

Studies of Flu Tool, a computer application that guides health care decision-making, suggests that patients are willing to use these types of resources.

lungs
August 9, 2012

New therapeutic target for cold, flu viruses identified

Viruses that cause acute respiratory infections — such as human metapneumovirus (HMPV) and flu — impair a set of immune system cells that should clear the virus from the lungs.
Now, Vanderbilt University investigators have discovered the signaling pathway that disables these immune cells.

August 9, 2012

Team creates new view of body’s infection response

A new 3-D view of the body’s response to infection — and the ability to identify proteins involved in the response — could point to novel biomarkers and therapeutic agents for infectious diseases.